Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Sage_Therapeutics
|
| gptkbp:clinical_trial |
Phase 2b/3 trial
|
| gptkbp:focus |
neuropsychiatric disorders
|
| gptkbp:founded |
gptkb:2015
|
| gptkbp:founder |
gptkb:William_J._Mc_Gowan
|
| gptkbp:goal |
develop treatments for depression
|
| gptkbp:headquarters |
gptkb:Radnor,_Pennsylvania
|
| https://www.w3.org/2000/01/rdf-schema#label |
Neuro Rx
|
| gptkbp:partnership |
Cure Pharmaceutical
|
| gptkbp:products |
NRX-101
|
| gptkbp:research_areas |
psychiatry
|
| gptkbp:website |
www.neurorx.com
|